High Dose Vitamin C (ASCOR®)
High Dose Vitamin C (ASCOR®)
High-dose intravenous (IV) vitamin C has shown significant benefits for cancer patients when used as a complementary therapy alongside conventional cancer treatments.
Here are some of the key benefits:
1. Selective Cytotoxicity: IV vitamin C, when administered at high doses, can selectively target and kill cancer cells while leaving healthy cells largely unharmed. This is due to the ability of high-dose vitamin C to generate hydrogen peroxide, which cancer cells are more vulnerable to compared to normal cells.
2. Improved Outcomes: Studies have demonstrated that the addition of high-dose IV vitamin C to conventional cancer treatments, such as chemotherapy and radiation therapy, can enhance the effectiveness of these therapies, leading to improved treatment outcomes and better prognosis for patients.
3. Reduced Side Effects: High-dose IV vitamin C has been shown to mitigate the side effects associated with conventional cancer treatments. It can help alleviate fatigue, nausea, and other symptoms, improving the patient's quality of life during the treatment process.
4. Immune System Support: Vitamin C is essential for the proper functioning of the immune system. By administering high-dose IV vitamin C, cancer patients can experience an enhanced immune response, which can help the body better fight against the cancer cells.
5. Antioxidant Protection: IV vitamin C acts as a powerful antioxidant, protecting healthy cells from the oxidative stress and damage caused by cancer and its treatments. This can help preserve cellular function and promote overall health.
6. Synergistic Effects: When used in combination with other complementary therapies, such as IV ALA, high-dose IV vitamin C can provide synergistic benefits, further enhancing the effectiveness of the overall treatment approach
It's important to note that the use of high-dose IV vitamin C in cancer treatment should be closely supervised by healthcare professionals, as it requires careful monitoring and dosage adjustments based on the individual patient's needs and response to the therapy.
MD consult required.
Committed to Best Outcomes and Patient Centered Care
At the Infusion Center of NJ, Dr. Weiss and his team are renowned for their expertise in facilitating comprehensive care for patients, particularly in collaboration with oncology and integrative oncology specialists. This collaborative approach ensures that patients receive the most well-rounded and effective treatment plans.
The center's focus on integrative care is exemplified by their use of FDA-approved Ascor, a high-dose intravenous vitamin C (IV-C) therapy. Ascor is a pure form of vitamin C, free from any allergens, additives, or preservatives, making it a safe and effective option for patients.
When working with oncology and integrative oncology professionals, Dr. Weiss and the Infusion Center of NJ team take a multidisciplinary approach to address the unique needs of each patient.
By leveraging their expertise in integrative medicine and their commitment to patient-centered care, Dr. Weiss and the Infusion Center of NJ are at the forefront of providing comprehensive and collaborative support for individuals facing cancer and other complex health challenges.